Redeye provides a brief comment on the subscription rate of Lipigon's warrant TO3.
Redeye embraces the collaboration with Hanger, a leading amputee care and prosthetics provider with ...
Gapwaves announced its first Asian tier-1 customer with a development order worth SEK5.
PMD is expanding in the UK, Germany and the US, and as a result, the company is proposing a rights i...
Redeye comments on the news that Moberg Pharma has secured the exercise of warrants and entered into...
Redeye ger en kort kommentar kring expertmötet om Donanemab.
Scanfil downgraded its full-year guidance on 10 June due to overall demand weakness.
Weakness seen in Q1 has continued in Q2 leading Scanfil to downgrade its full year net sales guidanc...
Unique investment company that compares favourably to peers High exposure to private assets NAV disc...
Redeye provides a brief comment on the new partnership with Mid Sweden University and Sandvik.
CirChem (”CirChem” eller ”Bolaget”) meddelade den 10 juni 2024 att Bolaget erhållit den första inter...
We had a chat with Justin Pierce, CEO of the Magle Group, and Marcus Larsson, CEO of Amniotics, abou...
Gapwaves has signed a non-binding letter of intent (LOI) with the undisclosed tier-1 customer.
Redeye briefly comments on Arise's press release from last week, stating that the earn-out for proje...
Trots tuffa jämförelsetal presenterade Systemair en rapport för det fjärde kvartalet som överträffad...
Huddlestock Fintech AS (“Huddlestock” or the “Company”) first quarter of 2024 demonstrated strong an...
I-Tech recently published that the BPC committee has adopted the previous interpretation of the endo...
ECHA's BPC adopts opinion that Medetomidine has ED properties European Commission now to decide on p...
The third quarter was a breakthrough quarter for ODI Pharma AB (”ODI Pharma” or the ”Company”), with...
Windon Energy Group AB (”Windon” eller ”Bolaget”) första kvartal var tuffare avseende de rapporterad...
